Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.43 USD | +4.29% | +2.97% | -73.59% |
May. 09 | Genprex, Inc Announces Executive Changes | CI |
May. 09 | Genprex, Inc Announces Executive Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 5.1M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -32M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.42
x | P/E ratio 2025 * |
-0.87
x | Employees | 26 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.23% |
1 day | +4.29% | ||
1 week | +2.97% | ||
Current month | +7.05% | ||
1 month | -20.85% | ||
3 months | -46.94% | ||
6 months | -72.51% | ||
Current year | -73.59% |
Managers | Title | Age | Since |
---|---|---|---|
Ryan Confer
CEO | Chief Executive Officer | 42 | 11-05-31 |
Kate Combs
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Mark Berger
CTO | Chief Tech/Sci/R&D Officer | 69 | 21-09-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brent Longnecker
BRD | Director/Board Member | 67 | 20-03-17 |
Ryan Confer
CEO | Chief Executive Officer | 42 | 11-05-31 |
Director/Board Member | 51 | 20-03-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 2.43 | +4.29% | 19,993 |
24-05-08 | 2.33 | -6.05% | 23,024 |
24-05-07 | 2.48 | -5.13% | 31,476 |
24-05-06 | 2.614 | +7.13% | 77,631 |
24-05-03 | 2.44 | +3.39% | 23,002 |
Delayed Quote Nasdaq, May 09, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-73.59% | 5.1M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.97% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- GNPX Stock